The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test

被引:25
作者
Costall, B [1 ]
Naylor, RJ [1 ]
机构
[1] UNIV BRADFORD, SCH PHARM, POSTGRAD STUDIES PHARMACOL, BRADFORD BD7 1DP, W YORKSHIRE, ENGLAND
关键词
5-HT2; and; 5-HT4; receptors; benzodiazepines; anxiolytic-like agents; disinhibition;
D O I
10.1038/sj.bjp.0701513
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The ability of 5-HT2 and 5-HT4 receptor antagonists to modify the disinhibitory profile of diazepam and other agents was investigated in male BKW mice in the light/dark test box. 2 The 5-HT2A/2B/2C receptor antagonists ritanserin, MDL11939 and RP62203 and also methysergide, which failed to modify mouse behaviour when administered alone, caused dose-related enhancements (4 to 8 fold) in the potency of diazepam to disinhibit behavioural responding to the aversive situation of the test box. 3 Ritanserin was shown to enhance the disinhibitory potency of other benzodiazepines, chlordiazepoxide (4 fold), temazepam (10 fold) and lorazepam (10 fold), the 5-HT1A receptor ligands, 8-OH-DPAT (25 fold), buspirone (100 fold) and lesopitron (500 fold), the 5-HT3 receptor antagonists, ondansetron (100 fold) R(+)-zacopride (100 fold) and S(-)-zacopride (greater than a 1000 fold), the substituted benzamides, sulpiride (10 fold) and tiapride (5 to 10 fold) and the cholecystokinin (CCK)(A) receptor antagonist, devazepide (100 fold). It also reduced the onset of action of disinhibition following treatment with the 5-HT synthesis inhibitor parachlorophenylalanine. Ritanserin failed to enhance the disinhibitory effects of the CCKB receptor antagonist CI-988, the angiotensin AT(1) receptor antagonist losarten or the angiotensin converting enzyme inhibitor ceranapril. 4 The 5-HT4 receptor antagonists SDZ205-557, GR113808 and SB204070 caused dose-related reductions in the disinhibitory effect of diazepam, returning values to those shown in vehicle treated controls. The antagonists failed to modify mouse behaviour when administered alone. 5 GR113808 was also shown to cause a dose-related antagonism of the disinhibitory effects of chlordiazepoxide, lorazepam, 8-OH-DPAT, buspirone, lesopitron, ondansetron, R(+)-zacopride, sulpiride, tiapride, devazepide, CI-988, losarten, ceranapril and parachlorophenylalanine. 6 It was concluded that in BKW mice (a) the failure of 5-HT2 and 5-HT4 receptor antagonists when administered alone to modify behaviour in the light/dark test indicates an absence of an endogenous 5-HT tone at the 5-HT2 and 5-HT4 receptors and (b) the enhancement by the 5-HT2 receptor antagonists and attenuation by the 5-HT4 receptor antagonists of drug-induced disinhibition indicates a plurality of 5-HT receptor involvement in the mediation of drug-induced disinhibitory profiles in the mouse.
引用
收藏
页码:1105 / 1118
页数:14
相关论文
共 84 条
  • [1] ABELSON JL, 1990, ARCH GEN PSYCHIAT, V47, P395
  • [2] PRECLINICAL PHARMACOLOGY OF FG5893 - A POTENTIAL ANXIOLYTIC DRUG WITH HIGH-AFFINITY FOR BOTH 5-HT1A AND 5-HT2A RECEPTORS
    ALBINSSON, A
    BJORK, A
    SVARTENGREN, J
    KLINT, T
    ANDERSSON, G
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 261 (03) : 285 - 294
  • [3] HANDLING HISTORY OF RATS MODIFIES BEHAVIORAL-EFFECTS OF DRUGS IN THE ELEVATED PLUS-MAZE TEST OF ANXIETY
    ANDREWS, N
    FILE, SE
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 235 (01) : 109 - 112
  • [4] Barnes N M, 1990, Neuroreport, V1, P20, DOI 10.1097/00001756-199009000-00006
  • [5] PROFILES OF INTERACTION OF R(+)/S(-)-ZACOPRIDE AND ANXIOLYTIC AGENTS IN A MOUSE MODEL
    BARNES, NM
    CHENG, CHK
    COSTALL, B
    GE, J
    KELLY, ME
    NAYLOR, RJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 218 (01) : 91 - 100
  • [6] DIFFERENTIAL MODULATION OF EXTRACELLULAR LEVELS OF 5-HYDROXYTRYPTAMINE IN THE RAT FRONTAL-CORTEX BY (R)-ZACOPRIDE AND (S)-ZACOPRIDE
    BARNES, NM
    CHENG, CHK
    COSTALL, B
    GE, J
    NAYLOR, RJ
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (01) : 233 - 239
  • [7] 5-HT RECEPTORS AS TARGETS FOR THE DEVELOPMENT OF NOVEL ANXIOLYTIC DRUGS - MODELS, MECHANISMS AND FUTURE-DIRECTIONS
    BARRETT, JE
    VANOVER, KE
    [J]. PSYCHOPHARMACOLOGY, 1993, 112 (01) : 1 - 12
  • [8] WITHDRAWAL SYNDROME FOLLOWING SUBCHRONIC TREATMENT WITH ANXIOLYTIC AGENTS
    BARRY, JM
    COSTALL, B
    KELLY, ME
    NAYLOR, RJ
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1987, 27 (02) : 239 - 245
  • [9] 5-HT2 RECEPTOR SUBTYPES - A FAMILY RE-UNITED
    BAXTER, G
    KENNETT, G
    BLANEY, F
    BLACKBURN, T
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (03) : 105 - 110
  • [10] BLIER P, 1993, MED SCI SYMP SER, V5, P55